as of Jul 17
BDX
DefensiveBecton, Dickinson and Company
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments.
Close · 3M
-6.64%
Held by 1 AI ETF
Signal performance
Each tracked ETF's moves on this stock, grouped by fund. Returns are measured from the signal date to the latest close — hypothetical, no commissions or slippage.
AIVL · Weight increase · 2d
BDX currently trades at $158.17, representing 75% of its 52-week high, having delivered a -8.5% return over the past year despite a recent +5.8% gain in 30 days. This market positioning places Becton, Dickinson and Company firmly within the value-factor pool that AIVL targets for potential investments. AIVL's AI, designed to distinguish genuine value from value traps using fundamentals like margins and debt alongside valuation metrics such as P/B and P/E, likely weighted BDX's low PBR of 2.1 and its significant price discount from its peak. This assessment occurred even with a PER of 38.3 and ROE of 4.54%, with the consecutive weight increase from July 14 to July 16 indicating the system's re-evaluation confirmed its allocation.
weight 1.056% → 1.104% (+0.047 pp)·stock up 9.9% in the 30 days before
Jul 16·entry $159.93·now $154.48Fresh
AIVL · Weight increase · 2d
The detected pattern of a consecutive weight increase for BDX within AIVL suggests the AI manager identifies a persistent underlying value proposition. Despite its relatively high PER of 36.93 and modest ROE of 4.54%, the stock's current price of $150.65, sitting near the lower end of its 52-week range and 72% below its annual high, aligns with AIVL's mandate to find value-tilted US stocks. This sustained allocation indicates the AI, which scrutinizes fundamentals like margins and return on capital alongside valuation metrics, perceives BDX as a genuine value opportunity rather than a value trap, especially given its PBR of 2.1. The AI is likely signaling conviction that BDX’s recent price declines of 11.4% over 90 days and 15.2% over a year present an entry point based on its proprietary scoring.
weight 1.056% → 1.073% (+0.017 pp)·stock up 4.1% in the 30 days before
Jul 13·entry $153.83·now $154.48Fresh
AIVL · Weight decrease · 2d
Becton, Dickinson and Company's PER of 36.93, combined with a relatively low ROE of 4.54% and revenue growth of 2.39%, presents a challenging profile for AIVL's AI, which explicitly seeks to distinguish genuine value from potential value traps using fundamentals and valuation metrics such as return on capital and P/E. While the company's PBR stands at 2.1, the AI likely evaluates the high earnings multiple against its profitability and growth, concluding it may not represent the deep value sought within its pre-filtered US value-factor pool. This AI assessment aligns with BDX's longer-term price performance, having delivered a -12.8% return over 90 days and -11.1% over the past year, placing its current price at 72% of its 52-week high despite a recent 30-day bounce. Consequently, AIVL's periodic rebalancing mechanism, guided by these underlying financial and market signals, has resulted in the observed consecutive decrease in BDX's weight within the portfolio.
weight 1.088% → 1.056% (-0.032 pp)·stock up 0.6% in the 30 days before
Jul 9·entry $150.85·now $154.48
AIVL · Accumulation · 5d
BDX's PBR of 2.1 places it within AIVL's pre-filtered US value-factor pool, which is the initial universe for the fund's AI selection. While BDX shows a PER of 37.85 and modest ROE of 4.54%, AIVL's AI system evaluates deeper fundamentals like margins and debt to discern genuine value from potential traps. The AI's scoring triggered a gradual accumulation of BDX, starting late June when the stock traded at $150.56, near 72% of its 52-week high following a -14.7% 90-day return. This sustained increase in AIVL's holding, from 1.0293% to 1.1053% by early July, suggests the AI identified specific attributes aligning with its value thesis at a favorable price point, prompting the rebalancing activity.
weight 1.029% → 1.088% (+0.059 pp)·stock up 4.5% in the 30 days before
Jul 7·entry $156.30·now $154.48Fresh
AIVL · Accumulation · 5d
WisdomTree's AIVL ETF, which scores names within a pre-filtered US value-factor pool, appears to have identified BDX as a compelling candidate after its recent price depreciation. The fund's AI, specifically tasked with distinguishing genuine value from value traps within an already-value-tilted universe, likely found the stock's current price at 74% of its 52-week high, following a -11.5% 90-day return, to be attractive. Although BDX carries a PER of 37.85, the AI's model considers additional valuation metrics like a PBR of 2.1 and fundamental analysis, potentially revealing an improving long-term outlook. This gradual accumulation, increasing the weight from 1.0066% to 1.1053% over several days, reflects the ETF's periodic rebalancing approach for its approximately 100 US value stocks, rather than daily adjustments.
weight 1.007% → 1.081% (+0.074 pp)·stock up 6.8% in the 30 days before
Jul 6·entry $155.54·now $154.48Fresh
AIVL · Accumulation · 6d
BDX trades at $158.08, 75% of its 52-week high, following a 90-day decline of 13.4% and a 1-year return of -6.1%, despite a recent 30-day rebound of 7.6%. This positions the stock in a specific spot within its price history, presenting a potential entry point for value-focused strategies. The WisdomTree AI-managed AIVL, which sifts for value within a pre-filtered US value universe using fundamentals and valuation metrics, likely identified BDX as a candidate after this decline. Its price-to-book ratio of 2.1, coupled with a modest revenue growth of 2.39%, aligns with criteria for a stock potentially undervalued after its recent dip, rather than a growth play. Despite a higher PER of 37.85 and a lower return on equity of 4.54%, the gradual increase in AIVL’s weight from 0.9737% to 1.1053% suggests the AI discerned underlying value beyond these headline figures, perhaps seeing a temporary undervaluation relative to its true earnings power or future prospects, distinguishing it from a value trap within its rebalancing cycles.
weight 0.974% → 1.105% (+0.132 pp)·stock up 9.5% in the 30 days before
Jul 2·entry $158.08·now $154.48Fresh
AIVL · Accumulation · 5d
AIVL's AI-driven methodology identifies US value stocks by evaluating fundamentals and valuation metrics within a pre-filtered pool. The significant price depreciation of BDX, evidenced by its current $152.90 trading at 73% of its 52-week high and a -17.1% 90-day return, likely positioned the healthcare company favorably within AIVL's value-tilted universe. Within this context, the AI's role is distinguishing genuine value from value traps, and its analysis appears to have identified BDX as an appealing holding despite its PER of 37.85, possibly weighing its PBR of 2.1 and the recent price declines more heavily. Consistent with its periodic rebalancing of approximately 100 US value stocks, AIVL incrementally increased its allocation to BDX, moving from 1.0033% to 1.0712% over a two-week period, indicating a deliberate accumulation at these price levels.
weight 1.003% → 1.056% (+0.053 pp)·stock up 5.2% in the 30 days before
Jul 1·entry $152.90·now $154.48Fresh
AIVL · Weight increase · 4d
BDX's financial picture includes a PBR of 2.1, which can be appealing for value, yet also a PER of 35.73 and a ROE of 4.54%. WisdomTree's AIVL, which employs AI to discern genuine value within a pre-filtered US value-factor universe, likely identified a compelling opportunity despite these mixed fundamentals. The stock's current price, at 74% of its 52-week high following prior 90-day and 1-year price depreciation, appears to be a key factor in this assessment. Consequently, AIVL consistently increased its weight in BDX from 1.0066% to 1.0712% between June 23 and June 26, suggesting the AI's analysis of underlying fundamentals like margins and debt, alongside valuation, pointed to an overlooked value proposition.
weight 0.974% → 1.071% (+0.098 pp)·stock up 5.9% in the 30 days before
Jun 26·entry $155.92·now $154.48Fresh
AIVL · Weight increase · 3d
Trading at $155.92, BDX is positioned significantly below its 52-week high, at 74% of that peak, following 90-day and one-year returns of -14.6% and -9.5% respectively. This substantial retreat in price likely brought the stock to the attention of AIVL's AI, which screens for US value names from a pre-filtered pool. The WisdomTree AI fund identified BDX as a genuine value, likely due to its PBR of 2.1, despite a PER of 35.73 and a 4.54% ROE, concluding it was not a value trap when considering its 2.39% revenue growth and broader fundamental profile. Consequently, AIVL made consecutive weight increases in BDX, moving from 0.9737% to 1.0379% between June 22 and June 25, reflecting the AI's growing conviction in the healthcare stock at this valuation level.
weight 0.974% → 1.038% (+0.064 pp)·stock up 2.5% in the 30 days before
Jun 25·entry $151.38·now $154.48Drifting
AIVL · Weight increase · 2d
AIVL, WisdomTree's AI-managed ETF specifically designed to score names within a pre-filtered US value-factor pool and distinguish genuine value from value traps, initiated consecutive weight increases in Becton, Dickinson and Company following the stock’s significant price depreciation. With BDX trading at $147.77, placing it at 70% of its 52-week high, the AI's fundamental and valuation metric analysis likely identified the company as an attractive value opportunity, with its PBR of 2.1 contributing to this assessment. The observed increases on June 23 and June 24, moving the position from 0.9737% to 1.0293% as the ETF rebalances periodically within its portfolio of roughly 100 US value stocks, indicate the AI's algorithms affirmed BDX's appeal as a compelling value play.
weight 0.974% → 1.029% (+0.056 pp)·stock up 0.1% in the 30 days before
Jun 24·entry $147.77·now $154.48Drifting
AIVL · Weight decrease · 7d
Becton, Dickinson and Company's P/E ratio of 34.97 and P/B of 2.1, alongside a 4.54% ROE and 2.39% revenue growth, presented a profile the WisdomTree AIVL fund's AI likely deemed inconsistent with genuine value within its US value-factor universe. The consecutive weight decrease, observed from 1.0899% to 0.9737% between June 5th and June 22nd, coincides with BDX trading at its 52-week low of $140.71 and registering significant negative 30-day and 90-day returns of -5.8% and -22.1% respectively. Despite the stock's discounted price at 67% of its 52-week high, the AI's continuous reduction in allocation suggests BDX's underlying fundamentals and valuation metrics, when measured against AIVL's criteria for distinguishing genuine value from value traps, no longer met the algorithm's requirements for portfolio inclusion.
weight 1.090% → 0.974% (-0.116 pp)·stock down 4.2% in the 30 days before
Jun 22·entry $140.71·now $154.48
AIVL · Weight decrease · 6d
The consecutive, measured reduction in BDX's weight, observed over several days, aligns with AIVL's periodic rebalancing approach rather than abrupt daily adjustments. Despite BDX's price approaching its 52-week low of $141.61, the AI's assessment likely identified its PER of 34.55 and a 4.54% ROE as misaligned with strong value characteristics, even within a pre-filtered US value-factor universe. This combination of modest revenue growth at 2.39% alongside elevated valuation multiples and low return on capital would signal to the AI a potential value trap, a scenario its algorithm is specifically designed to distinguish from genuine undervaluation. Therefore, while the stock traded near its 52-week floor with significant negative recent returns, the AI's systematic review of fundamentals and valuation metrics indicated a stock that, at this price level, did not warrant its prior allocation based on AIVL's specific investment methodology.
weight 1.090% → 1.003% (-0.087 pp)·stock down 2.0% in the 30 days before
Jun 18·entry $143.98·now $154.48
AIVL · Weight decrease · 5d
AIVL's multi-day adjustment shows a consistent, gradual decrease in its Becton, Dickinson and Company (BDX) weighting, moving from 1.0779% to 1.0066% over eight trading days. This methodical reduction, occurring while BDX trades at $141.61—near its 52-week low after a -31.7% 90-day return—reflects the AI's objective to distinguish genuine value from value traps within its pre-filtered US value-factor universe. The AI's assessment likely weighed BDX's high 35.44 PER and low 4.54% Return on Equity against its 2.39% revenue growth, suggesting that even at current price levels, the stock's underlying financial health does not satisfy the fund's criteria for a compelling value investment.
weight 1.090% → 1.007% (-0.083 pp)·stock up 1.2% in the 30 days before
Jun 16·entry $145.16·now $154.48
AIVL · Weight decrease · 4d
BDX currently trades at $145.52, sitting near its 52-week low of $142.35 after a significant 29.5% decline over the past 90 days. This price compression, which often signals value, appears to have prompted a re-evaluation by AIVL's AI, designed to distinguish genuine value from potential value traps within its US value stock universe. Despite the stock being at 69% of its 52-week high, the AI's assessment, factoring in fundamentals such as the 4.54% Return on Equity and 2.39% revenue growth, alongside a 35.44 Price-to-Earnings ratio, likely indicated underlying issues. The consecutive decrease in AIVL's weight for BDX from June 8th to June 12th suggests the AI determined these financial characteristics did not sufficiently align with its criteria for a sound value investment, viewing the situation as a value trap rather than an undervalued opportunity.
weight 1.090% → 1.022% (-0.067 pp)·stock up 1.4% in the 30 days before
Jun 12·entry $146.24·now $154.48
AIVL · Weight decrease · 3d
WisdomTree's AIVL displayed a gradual, consecutive weight reduction in Becton, Dickinson and Company, moving from 1.0899% on June 5th to 1.0405% by June 11th, even as the stock traded near its 52-week low of $142.35. This systematic decrease by the AI-managed fund aligns with its core mandate of distinguishing genuine value from value traps within a pre-filtered US value pool. BDX's elevated P/E ratio of 35.44 and low 4.54% Return on Equity, coupled with modest 2.39% revenue growth, likely prompted the AI to reduce exposure, despite the recent price depreciation of almost 29% over 90 days. The AI, tasked with scoring names based on fundamentals and valuation metrics, likely identified these figures as indicating that BDX may not represent a genuinely undervalued healthcare opportunity, preferring measured divestment over increasing allocation to a potential value trap.
weight 1.090% → 1.040% (-0.049 pp)·stock down 0.1% in the 30 days before
Jun 11·entry $147.35·now $154.48
AIVL · Weight decrease · 2d
WisdomTree's AIVL fund, which leverages AI to distinguish genuine value from value traps within its approximately 100 US value stock holdings, implemented a consecutive weight decrease in Becton, Dickinson and Company. This reduction reflects the AI's periodic re-evaluation of BDX's financial health and valuation, a key part of the fund's methodology. The AI's scoring, which considers fundamentals and valuation metrics, likely flagged concerns regarding the stock's PER of 35.44, which is elevated for a value-oriented investment. Such a valuation, combined with a relatively low ROE of 4.54%, could indicate a diminishing return on capital or an unattractive value proposition for the AI, prompting the adjustment within its rebalancing schedule.
weight 1.090% → 1.064% (-0.026 pp)·stock up 3.2% in the 30 days before
Jun 10·entry $147.79·now $154.48
AIVL · Weight increase · 2d
weight 1.037% → 1.090% (+0.053 pp)·stock up 4.4% in the 30 days before
Jun 5·entry $151.16·now $154.48Drifting
AIVL · Weight increase · 2d
WisdomTree's AIVL, designed to identify genuine value within its approximately 100 US value stocks using AI-driven scoring, adjusted its allocation to Becton, Dickinson and Company with a notable weight increase to 1.0384% by June 1. This move likely reflects the fund's AI algorithm identifying BDX as a compelling value opportunity after its significant share price contraction, evidenced by a 90-day return of -28.4% placing it near its 52-week low of $142.35. The AI's criteria, which weigh fundamentals like margins and return on capital alongside valuation metrics such as P/B and FCF yield, likely evaluated BDX's underlying business health as resilient enough to differentiate it from a mere value trap at current levels. Despite a 4.54% ROE, the algorithm may have found the PBR of 2.1, combined with the substantial price drop, made the stock sufficiently attractive within its rebalancing cycle to warrant this increased position.
weight 0.822% → 1.038% (+0.217 pp)·stock down 2.5% in the 30 days before
Jun 1·entry $145.33·now $154.48Drifting
AIVL · Weight decrease · 2d
The AI ETF is likely reducing its BDX weight due to the stock's high P/E ratio (35.86) despite weak underlying fundamentals, indicated by low revenue growth (2.39%) and poor return on equity (4.54%). Retail investors should interpret such sustained AI selling as a cautionary signal, prompting deeper scrutiny of companies with high valuations that lack robust profitability and growth.
weight 0.878% → 0.813% (-0.065 pp)·stock down 7.2% in the 30 days before
May 11·entry $143.15·now $154.48
AIVL · Weight decrease · 3d
The AI ETF likely initiated the consecutive weight decrease for BDX due to its low Return on Equity of 6.93%, which suggests inefficient capital utilization given its relatively high Price-to-Earnings ratio of 23.74. This indicates the AI perceives the stock as potentially overvalued relative to its profitability and efficiency. For retail investors, this highlights the importance of evaluating a company's profitability and efficiency metrics, such as ROE, in conjunction with valuation ratios like PER, to ensure a stock's market price is justified by its underlying financial health.
weight 0.859% → 0.823% (-0.036 pp)·stock down 6.6% in the 30 days before
May 6·entry $144.76·now $154.48
AIVL · Weight increase · 2d
stock down 4.5% in the 30 days before
May 1·entry $149.31·now $154.48Drifting
Sell signals show what the stock did after the AI exited. A negative number means the AI's exit was well-timed.